Cerus

Cerus CERS Stock

$1.85   -2.631577%
Add to favorites
Market Cap
$373.62M
LOW - HIGH [24H]
$1.82 - $1.95
VOLUME [24H]
$4.51M
P/E Ratio
0
Earnings per share
-$0.04
ISIN
US1570851014
Price   Prediction

Cerus Price Chart

Sorry, that's all we've gotfor now...

Cerus (CERS) stock price today is 1.85 USD on Tech Market Middle (-2.63% on the day). Updated .

Cerus CERS Financial and Trading Overview

Cerus stock price 1.85 USD
Previous Close 1.9 USD
Open 1.84 USD
Bid 2.09 USD x 200
Ask 2.76 USD x 200
Day's Range 1.82 - 1.95 USD
52 Week Range 1.47 - 3.47 USD
Volume 4.51M USD
Avg. Volume 2.09M USD
Market Cap 373.62M USD
Beta (5Y Monthly) 1.853
PE Ratio (TTM) N/A
EPS (TTM) -0.04 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 5.13 USD

CERS Valuation Measures

Enterprise Value 392.13M USD
Trailing P/E N/A
Forward P/E 123.333336
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.6490275
Price/Book (mrq) 4.9333334
Enterprise Value/Revenue 1.731
Enterprise Value/EBITDA -524.234

Trading Information

Cerus Stock Price History

Beta (5Y Monthly) 1.853
52-Week Change 17.28%
S&P500 52-Week Change 8.67%
52 Week High 3.47 USD
52 Week Low 1.47 USD
50-Day Moving Average 2.31 USD
200-Day Moving Average 2.42 USD

CERS Share Statistics

Avg. Volume (3 month) 2.09M USD
Avg. Daily Volume (10-Days) 3.66M USD
Shares Outstanding 201.95M
Float 195.78M
Short Ratio 8.08
% Held by Insiders 3.60%
% Held by Institutions 76.01%
Shares Short 14.63M
Short % of Float 7.45%
Short % of Shares Outstanding 7.24%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -3.22%
Operating Margin (ttm) -1.090%
Gross Margin 51.83%
EBITDA Margin -0.33%

Management Effectiveness

Return on Assets (ttm) -0.73%
Return on Equity (ttm) -10.67%

Income Statement

Revenue (ttm) 226.57M USD
Revenue Per Share (ttm) 1.15 USD
Quarterly Revenue Growth (yoy) 9.50%
Gross Profit (ttm) 117.44M USD
EBITDA -748000 USD
Net Income Avi to Common (ttm) -7314000 USD
Diluted EPS (ttm) -0.04
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 57.11M USD
Total Cash Per Share (mrq) 0.28 USD
Total Debt (mrq) 74.96M USD
Total Debt/Equity (mrq) 98.16 USD
Current Ratio (mrq) 1.957
Book Value Per Share (mrq) 0.375

Cash Flow Statement

Operating Cash Flow (ttm) 3.5M USD
Levered Free Cash Flow (ttm) 2.13M USD

Profile of Cerus

Country United States
State CA
City Concord
Address 1220 Concord Avenue
ZIP 94520
Phone 925 288 6000
Website https://www.cerus.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 261

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Systems for platelets plasma, and cryoprecipitation, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells intended for transfusion; INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma and cryoprecipitate reduced; and INTERCEPT Illuminator, an LED-based device for blood component treatment. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was formerly known as CERUS TECHNOLOGIES INC and changed its name to Cerus Corporation in July 1996. The company was incorporated in 1991 and is headquartered in Concord, California.

Q&A For Cerus Stock

What is a current CERS stock price?

Cerus CERS stock price today per share is 1.85 USD.

How to purchase Cerus stock?

You can buy CERS shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Cerus?

The stock symbol or ticker of Cerus is CERS.

Which industry does the Cerus company belong to?

The Cerus industry is Medical Devices.

How many shares does Cerus have in circulation?

The max supply of Cerus shares is 201.95M.

What is Cerus Price to Earnings Ratio (PE Ratio)?

Cerus PE Ratio is now.

What was Cerus earnings per share over the trailing 12 months (TTM)?

Cerus EPS is -0.04 USD over the trailing 12 months.

Which sector does the Cerus company belong to?

The Cerus sector is Healthcare.

Cerus CERS included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 22617.73 USD —
-5.28
10.6B USD — 22513.01 USD — 23837.76 USD — — 10.6B USD —
us US Tech Global Market Composite NQGM US 1743.91 USD —
-3.66
— — 1738.23 USD — 1808.43 USD — — — —
us US Tech Health Care IXHC US 1282.67 USD —
-1.79
— — 1279.99 USD — 1317.94 USD — — — —
us US Tech Composite Total Return XCMP US 27958.09 USD —
-5.28
— — 27828.65 USD — 29466.09 USD — — — —
us US Tech Biotechnology Total Retu XNBI US 7414.87 USD —
-1.68
— — 7398.95 USD — 7631.86 USD — — — —
$2.09T
Total marketcap
$110.95B
Total volume
BTC 57.95%   •   ETH 9.84%
Dominance
Select currency